洛匹那韋代謝物M1
|
|
|
- CAS號:
- 192725-39-6
- 英文名:
- Lopinavir Metabolite M-1
- 英文別名:
- 4-Oxo-ABT-378;Lopinavir Impurity 22;Lopinavir IP Impurity E;Lopinavir Metabolite M-1;Lopinavir IP Impurity E( Impurity 22);Lopinavir 4-Oxo Analog/ Lopinavir Metabolite M1;(S)-N-((2S,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-methylbutanamide;(aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de;(aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- d;(aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de
- 中文名:
- 洛匹那韋代謝物M1
- 中文別名:
- 洛匹那韋相關(guān)雜質(zhì);洛匹那韋代謝物M1;洛匹那韋IP雜質(zhì)E(雜質(zhì)22)
- CBNumber:
- CB21176399
- 分子式:
- C37H46N4O6
- 分子量:
- 642.792
- MOL File:
- 192725-39-6.mol
|
|
|
洛匹那韋代謝物M1化學性質(zhì)
-
熔點:
-
106-108°C
-
|
-
密度:
-
1?+-.0.06 g/cm3(Predicted)
-
|
-
儲存條件:
-
-20°C Freezer
-
|
-
溶解度:
-
Chloroform (Slightly), Methanol (Slightly)
-
|
-
形態(tài):
-
Solid
-
|
-
酸度系數(shù)(pKa):
-
12.61±0.20(Predicted)
-
|
-
顏色:
-
Off-White
-
|
洛匹那韋代謝物M1性質(zhì)、用途與生產(chǎn)工藝
Lopinavir Metabolite M-1 是 Lopinavir 的活性代謝產(chǎn)物，以 0.7 pM 的 Ki 值抑制 HIV 蛋白酶。Lopinavir Metabolite M-1 在體外具有抗病毒活性。
IC50: 0.7 pM (HIV Protease)
Lopinavir Metabolite M-1 has antiviral activities in MT-4 cells, with an EC
50
of 1.413 μM.
洛匹那韋代謝物M1
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
192725-39-6, 洛匹那韋代謝物M1 相關(guān)搜索:
- Pharmaceuticals
- Non-nucleoside Reverse Transcriptase
- Metabolites & Impurities
- Intermediates & Fine Chemicals
- Various Metabolites and Impurities
- C37H46N4O6
- 洛匹那韋相關(guān)雜質(zhì)
- 洛匹那韋IP雜質(zhì)E(雜質(zhì)22)
- 洛匹那韋代謝物M1
- 192725-39-6
- Lopinavir IP Impurity E( Impurity 22)
- 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-, (αS)-
- (S)-N-((2S,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-methylbutanamide
- Lopinavir 4-Oxo Analog/ Lopinavir Metabolite M1
- Lopinavir IP Impurity E
- Lopinavir Impurity 22
- 4-Oxo-ABT-378
- (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de
- Lopinavir Metabolite M-1
- (αS)-N-[(1S,3S,4S)-4-[[(2,6-DiMethylphenoxy)acetyl]aMino]-3-hydroxy-5-phenyl-1-(phenylMethyl)pentyl]tetrahydro-α-(1-Methylethyl)-2,4-dioxo-1(2H)-pyriMidineacetaMi-
de
- (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de
- (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- d